3/6/24 17:21 | 3/4/24 | FOLD | Amicus Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | McGlynn Margaret G | NJ | D | | M.dm | 42 | 2.80 | 0 | 15 | 34 | 59 | D | | | | | | | | | | | | | | |
3/6/24 17:21 | 3/4/24 | FOLD | Amicus Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | McGlynn Margaret G | NJ | D | | S.dm | -200 | 13.35 | 0 | -15 | -20 | 59 | D | | | | | | | | | | | | | | |
6/13/23 16:47 | 6/10/23 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | McGlynn Margaret G | MD | D | | M.d | 0 | 0.00 | 0 | 3 | 443 | 4 | D | | | | | | | | | | | | | | |
1/17/23 18:03 | 1/13/23 | FOLD | Amicus Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | McGlynn Margaret G | PA | D | | M.d | 50 | 3.32 | 0 | 15 | 42 | 51 | D | | | | | | | | | | | | | | |
1/17/23 18:03 | 1/13/23 | FOLD | Amicus Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | McGlynn Margaret G | PA | D | | S.d | -195 | 13.03 | 0 | -15 | -23 | 51 | D | | | | | | | | | | | | | | |
6/21/22 20:47 | 6/17/22 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | McGlynn Margaret G | MD | D | | M.d | 0 | 0.00 | 0 | 1 | New | 1 | D | | | | | | | | | | | | | | |
5/4/22 19:37 | 5/2/22 | FOLD | Amicus Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | McGlynn Margaret G | PA | D | | M.d | 72 | 4.79 | 0 | 15 | 65 | 38 | D | | | | | | | | | | | | | | |
5/4/22 19:37 | 5/2/22 | FOLD | Amicus Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | McGlynn Margaret G | PA | D | | S.d | -105 | 6.99 | 0 | -15 | -28 | 38 | D | | | | | | | | | | | | | | |
4/12/22 16:05 | 4/8/22 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | McGlynn Margaret G | MA | D | | M.d | 638 | 127.54 | 0 | 5 | | 1 | D | | | | | | | | | | | | | | |
4/12/22 16:05 | 4/8/22 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | McGlynn Margaret G | MA | D | | S.d | -1,401 | 280.22 | 0 | -5 | -82 | 1 | D | | | | | | | | | | | | | | |
4/4/22 16:05 | 3/31/22 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | McGlynn Margaret G | MA | D | | M.d | 638 | 127.54 | 0 | 5 | | 1 | D | | | | | | | | | | | | | | |
4/4/22 16:05 | 3/31/22 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | McGlynn Margaret G | MA | D | | S.d | -1,311 | 262.27 | 0 | -5 | -82 | 1 | D | | | | | | | | | | | | | | |
2/1/22 16:09 | 1/28/22 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | McGlynn Margaret G | MA | D | | M.d | 638 | 127.54 | 0 | 5 | | 1 | D | | | | | | | | | | | | | | |
2/1/22 16:09 | 1/28/22 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | McGlynn Margaret G | MA | D | | S.d | -1,209 | 241.79 | 0 | -5 | -82 | 1 | D | | | | | | | | | | | | | | |